WAYNE, PA — Teleflex Incorporated (NYSE: TFX), a global provider of medical technologies designed to improve the health and quality of people’s lives, unveiled its 2023 Global Impact Report this week. The comprehensive document details the company’s recent strides in Corporate Social Responsibility (CSR) and sets ambitious goals for future sustainability and ethical governance efforts.
Liam Kelly, Chairman, President, and CEO of Teleflex, emphasized CSR’s central role in the company’s strategy. “Advancing Corporate Social Responsibility and an inclusive culture is a key priority for Teleflex,” Kelly stated. He underscored the company’s commitment to focusing on product innovation, patient care, employee welfare, and environmental stewardship as core components of its long-term growth plan.
The report aligns with standards set by the Global Reporting Initiative (GRI), the Sustainability Accounting Standards Board (SASB), and the Taskforce on Climate-Related Financial Disclosures (TCFD), demonstrating Teleflex’s adherence to globally recognized CSR and sustainability frameworks.
Cam Hicks, Corporate Vice President and Chief Human Resources Officer, expressed pride in the progress Teleflex has made in the past year. “The progress we made in 2023 is a testament to all of our employees who continue to push forward our CSR efforts with passion and diligence,” Hicks commented, highlighting the collective effort behind the company’s achievements.
Key achievements detailed in the 2023 Global Impact Report include:
- The Science Based Targets initiative (SBTi) validated Teleflex’s commitment to achieving net-zero greenhouse gas emissions across its value chain by 2050, acknowledging the company’s realistic pathway towards significantly reducing scope 1, 2, and 3 emissions.
- Teleflex improved its Environmental, Social, and Governance (ESG) ratings, receiving an AA rating from MSCI, favorable scores from ISS ESG QualityScore, and a reduced ESG Risk Rating from Morningstar Sustainalytics.
- The company’s investment in renewable energy was highlighted by the generation of over 7.5 GWh (gigawatt hours) of electricity through solar photovoltaic (PV) installations across seven manufacturing sites.
- In terms of supporting clinical research, Teleflex awarded 12 directed grants and 20 Investigator Initiated Study (IIS) grants in 2023, funneling nearly $8.5 million into clinical research grants.
These milestones reflect Teleflex’s ongoing commitment to CSR, particularly in the areas of ethics and governance, environmental sustainability, employee well-being, and community healthcare support. The report not only illustrates the company’s dedication to making a positive global impact but also positions Teleflex as a leader in integrating CSR into its business model.
Teleflex’s ambitious environmental targets and improvements in ESG ratings are particularly significant in today’s corporate landscape, where investors, customers, and the public increasingly demand transparency and responsibility in environmental and social governance. Such advancements are crucial for fostering a sustainable future and exemplify how corporations can lead by example in addressing global challenges.
By laying out a clear and actionable path towards sustainability and ethical operations, Teleflex Incorporated sets a precedent for the medical technology industry, showing that corporate success can go hand-in-hand with making a positive impact on society and the planet.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.